Atorvastatin Calcium Anhydrous
-
Post Date:
Aug 05,2019
-
Expiry Date:
Feb 01,2020
-
Detailed Description:
Cas No. :134523-03-8
-
CAS Registry Number:
134523-03-8
-
Synonyms:
;ATORVASTATIN CA;[r-(r*, r*)]-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylaminocarbonyl)-1h-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid calcium salt;1h-pyrrole-1-heptanoicacid,beta,delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methy calciumsalt(2:1),(r-(r*,r*))-lethyl)-3-phenyl-4-((phenylamino)carbonyl);delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-betcalci1h-pyrrole-1-heptanoicaci;pd134298-38a;ATORVASTATINCALCUIM;calcium (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-p ropan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoate;1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-calcium salt (2: 1), (R-(R*,R*))-;1H-Pyrrole-1-heptanoic acid,beta,delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-calcium salt (2: 1);(R-(R*,R*))-, Atorvastatin calcium;Atorvastatin calcium (USAN);Atorvastatin calcium salt;Atorvastatin calcium [USAN];C08078;Calcium (betaR,deltaR)-2-(p-fluorophenyl)-beta,delta-dihydroxy-5-isopr opyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoate (1:2);CI-981;D00887;DRG-0321;Lipibec;Lipitor;Lipitor (TN);LS-136974;PD 134298-38A;Prevencor;Sortis;Tahor;Torvast;YM-548;Atorvastatin Calsium;(3R,5R)-7-[2-(4-Fluorophenyl)-5-Isopropyl-3-Phenyl-4-(Pheynylcarbamoyl)Pyrrol-1-yl]-3,5-Dihydroheptanoic Acid,calcium salt;(3R,5R)-7-[2-(4-Fluorophenyl)-5-Isopropyl-3-Phenyl-4-(Pheynylcarbamoyl)Pyrrol-1-yl]-3,5–Dihydroheptanoic Acid,calcium salt;L-4;(3R,5R)-7-[2-(4-Fluorophenyl)-5-Isopropyl-3-Phenyl-4-(Pheynylcarbamoyl)Pyrrol-1-yl]-3,5–Dihydroheptanoic Acid,calcium salt(L-4);beta,delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-calcium salt(2:1);Atorvastatin Calcium Anhydrous;
-
Molecular Formula:
C66H68Ca2F2N4O10
-
Molecular Weight:
1195.4197264
-
Molecular Structure:
Inquiry